{'fraction_non_alphanumeric': 0.01284796573875803, 'fraction_numerical': 0.0, 'mean_word_length': 5.882352941176471, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
This week in Neurology®

The metabolic syndrome is now being recognized as an important clinical factor associated with a higher resistance to clot dissolution after IV thrombolysis in the setting of acute ischemic stroke. A derangement in endogenous fibrinolysis caused by insulin resistance may hamper arterial recanalization. Acute stroke patients meeting metabolic syndrome criteria may benefit from interventional (as opposed to IV) revascularization approaches.